颈动脉内膜切除术后再狭窄患者的临床结局
单中心1994–2022年连续1585例颈动脉内膜切除术(CEA)患者中,45例(2.8%)出现再狭窄,其中6例(13%)有症状、39例(87%)无症状。再狭窄后5年同侧卒中仅1例,见于单纯药物治疗亚组;5年卒中/死亡共11例(25%),单纯药物治疗组9例多于颈动脉支架置入(CAS)组2例(10% vs 37.5%,P=0.036)。
要点
- CEA后再狭窄发生率为2.8%,多数为无症状。
- 无症状再狭窄单纯药物治疗5年内未观察到同侧卒中。
- 再狭窄后5年卒中/死亡在药物治疗组高于CAS组。
核心结论
- 无症状再狭窄患者单纯药物治疗5年内未发生同侧卒中,主要死因为非神经并发症。
- 药物治疗可能是无症状再狭窄患者的可行选择,再干预必要性需进一步研究。
研究设计与样本
- 单中心三级转诊中心1994–2022年连续接受CEA的患者纳入研究。
- 共1585例患者,分为无再狭窄组与再狭窄组;再狭窄组按治疗策略分为CAS或单纯药物治疗。
主要发现
- 1585例中45例(2.8%)诊断CEA后再狭窄,其中6例(13%)有症状、39例(87%)无症状。
- 再狭窄后5年同侧卒中仅1例,发生于单纯药物治疗亚组。
- 单纯药物治疗亚组中1例有症状再狭窄发生于2002年CAS引入之前。
- 5年卒中/死亡共11例(25%),单纯药物治疗组9例多于CAS组2例(10% vs 37.5%,P=0.036)。
关键数值与推荐
- 再狭窄定义为CEA后诊断的再狭窄,发生率2.8%(45/1585)。
- 再狭窄中有症状者13%(6/45),无症状者87%(39/45)。
- 5年卒中/死亡:单纯药物治疗组10%(9例),CAS组37.5%(2例),P=0.036。
临床怎么用
- 无症状CEA后再狭窄可考虑单纯药物治疗并密切随访。
- 有症状再狭窄或需再干预者,CAS为可选治疗策略之一。
局限性
- 单中心回顾性设计,再狭窄样本量小(45例)。
- 单纯药物治疗亚组中部分病例发生于CAS引入前,存在时代偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To identify the clinical course of the patients with restenosis after carotid endarterectomy (CEA) based on treatment strategy and symptomatic status. METHODS: All consecutive patients who underwent CEA at a single tertiary referral center between 1994 and 2022 were enrolled. Patients were divided into 2 groups: subjects without restenosis and those with restenosis. The restenosis group was further subdivided based on treatment strategy into carotid artery stenting (CAS) or medical treatment alone. Primary outcome measures were the incidence of 5-year ipsilateral stroke, any stroke, and combined stroke/death post-restenosis. RESULTS: Among a total of 1585 patients, 45 (2.8%) were diagnosed with restenosis after CEA; 6 (13%) were symptomatic, and 39 (87%) were asymptomatic. Notably, only one 5-year ipsilateral stroke occurred in the medical treatment alone subgroup. In the medical treatment alone subgroup, one patient with restenosis that occurred before 2002, when CAS was introduced was symptomatic. Regarding primary outcome measures, 11 cases of 5-year stroke and death occurred (11, 25%), and a greater number was observed in the medical treatment alone subgroup (n = 9) than in the CAS subgroup (n = 2) (10% vs. 37.5%, P = 0.036). CONCLUSION: In asymptomatic patients with medical treatment alone subgroup, no cases of ipsilateral stroke were observed over a 5-year period, and the major cause of death were nonneurologic complications. Medical treatment may be a viable option for asymptomatic restenosis patients. Further research is needed to assess the necessity of reintervention in these cases.
引用
- Park JK, Yang SS, Park YM, et al. Clinical Outcomes of Restenosis Patients After Carotid Endarterectomy. Ann Vasc Surg. 2025. PMID: 40582451. doi:10.1016/j.avsg.2025.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。